DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Gretex Corporate Services Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·9 Oct 2026, 11:29 am

Gretex Corporate Services

Gretex Corporate Services Limited has informed the stock exchanges that it has received a Certificate of Registration under SEBI's (Depositories and Participants) Regulations, 2018. This regulatory clearance confirms that the company meets the necessary compliance standards to operate as a Depository Participant (DP).

For investors, this development is a positive signal, as it validates the company's operational framework and adherence to regulatory norms. It enhances the credibility of the firm, potentially opening doors to new business opportunities in the securities market. The stock is currently trading at ₹0.00.

Investors should monitor the company's future announcements regarding the commencement of its DP services and any updates on its business expansion plans. Keeping an eye on the stock's reaction to this regulatory milestone will provide further insight into market sentiment.